Temasek Holdings Private Ltd Takes Position in Danaher Corporation $DHR

Key Points

• Temasek Holdings Private Ltd has acquired a new stake in Danaher Corporation, purchasing 65,000 shares valued at approximately $13.33 million in the first quarter.
• Danaher reported earnings of $1.80 per share for the last quarter, exceeding estimates, with a revenue of $5.94 billion, up 3.4% year-over-year.
• Seventeen analysts have rated Danaher stock with a Buy rating, and the consensus price target is set at $246.35.

Temasek Holdings Private Ltd bought a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 65,000 shares of the conglomerate's stock, valued at approximately $13,325,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Teewinot Capital Advisers L.L.C. bought a new position in Danaher during the 1st quarter worth about $693,000. UniSuper Management Pty Ltd grew its holdings in Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock worth $34,954,000 after purchasing an additional 2,667 shares during the period. Scientech Research LLC acquired a new stake in Danaher during the first quarter worth approximately $589,000. Select Equity Group L.P. lifted its position in Danaher by 37.9% during the first quarter. Select Equity Group L.P. now owns 212,766 shares of the conglomerate's stock worth $43,617,000 after acquiring an additional 58,485 shares during the last quarter. Finally, Sandler Capital Management acquired a new stake in Danaher during the first quarter worth approximately $1,021,000. Institutional investors own 79.05% of the company's stock.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.20% of the company's stock.

Analyst Ratings Changes

DHR has been the subject of a number of analyst reports. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research report on Friday, July 11th. Evercore ISI decreased their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Wells Fargo & Company reduced their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Finally, Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average target price of $246.35.

Danaher Stock Performance

Shares of NYSE:DHR traded down $4.39 during mid-day trading on Tuesday, reaching $194.24. The company had a trading volume of 3,344,891 shares, compared to its average volume of 2,899,976. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market cap of $139.09 billion, a price-to-earnings ratio of 41.33, a PEG ratio of 2.77 and a beta of 0.75. The company's 50-day moving average price is $201.82 and its 200-day moving average price is $199.20. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher's revenue was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. Danaher's dividend payout ratio is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.